Overview
Dexamethasone Before Elective Cesarean Section at Term in Reducing Neonatal Respiratory Distress Syndrome
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2022-04-01
2022-04-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
Prophylactic antenatal administration of corticosteroid enhance fetal lung maturity and reduce the probability of respiratory morbidity in preterm births. assessment of administration of four doses intramuscular dexamethasone 48h before elective cesarean section at term in reducing the incidence of neonatal respiratory distress syndrome and NICU admission as a resultPhase:
Phase 4Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Ain Shams UniversityTreatments:
Dexamethasone
Dexamethasone 21-phosphate
Criteria
Inclusion Criteria:- Gestational age (37-39wks).
- Singleton pregnancy.
- Didn't receive any steroid treatment during pregnancy.
Exclusion Criteria:
- Undetermined gestational age
- Maternal chronic diseases (e.g: hypertension, DM-2) to avoid any side effects of
steroid use and to keep the pregnant 's case from getting worse.
- Congenital fetal malformations
- Emergency CS
- Pregnant refusing to participate in the study or unable to consent